Coexisting bipolar affective disorder and multiple sclerosis: The role of the pineal gland

References

• Abo T., Kawate T., Itoh K., Kumagai K. Studies on the bioperiodicity of the immune response. I. Circadian rhythms of human T, B and K cell traffic in the peripheral blood. Journal of Immunology 1981; 126: 1360–1363
   PubMed Web of Science ®Google Scholar
• Adams R. D., Victor M. Principles of neurology. McGraw-Hill Book Company, New York 1985; 669–717
   Google Scholar
• Bignami A., Gharardi D., Gallo G. Sclerosi a placche acuta a localizzazione 1 potalamica cons tintomologia psychica di tipo malinconico. Rivista Neurologica 1961; 31: 240–268
   PubMedGoogle Scholar
• Boyd J. H., Weissman N. M. Epidemiology. Handbook of affective disorders, E. S. Paykel. Guilford Press, New York 1982; 109–125
   Google Scholar
• Claveria L. E., Curzon G., Harrison M. J. G., Kantamaneni B. D. Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1974; 37: 715–718
   PubMed Web of Science ®Google Scholar
• Davidson D., Pullar I. A., Mawdsley C., Kinloch N., Yates M. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1977; 40: 741–745
   PubMed Web of Science ®Google Scholar
• Fieve R., Dunner D., Kimbarachi T. Lithium carbonate in affective disorders. Archives of General Psychiatry 1975; 32: 1541–1544
   PubMed Web of Science ®Google Scholar
• Flor Henry P. Schizophrenia-like reactions and affective psychoses associated with temporal lobe epilepsy: ethiological factors. American Journal of Psychiatry 1969; 126: 400–404
   PubMedGoogle Scholar
• Frick E., Scheid-Seydel L. Untersuchungen mit markirtem Globulin zur Frage der Abstammung der Liquoreiweisskorper. Klinische Wochenschrift 1958; 36: 857–863
   PubMedGoogle Scholar
• Garfield D. A. S. Multiple sclerosis and affective disorder: 2 case reports of mania with psychosis. Psychotherapy & Psychosomatics 1985; 44: 25–33
   PubMed Web of Science ®Google Scholar
• Goodstein R. K., Ferrell R. B. Multiple sclerosis presenting as depressive illness. Diseases of the Nervous System 1977; 38: 127–131
   PubMedGoogle Scholar
• Johansson B., Roos B. E. 5-hydroxyindoleactic acid in cerebrospinal fluid of patients with neurological diseases. European Neurology 1974; 11: 37–45
   PubMed Web of Science ®Google Scholar
• Joffe R. T., Lippert G. P., Gray T. A. Mood disorder and multiple sclerosis. Archives of Neurology 1987; 44: 376–378
   PubMed Web of Science ®Google Scholar
• Kellner C. H., Davenport Y., Post R. M., Ross R. J. Rapidly cycling bipolar disorder and multiple sclerosis. American Journal of Psychiatry 1984; 141: 112–113
   PubMed Web of Science ®Google Scholar
• Kemp K., Lion J. R., Magram G. Lithium in the treatment of a manic patient with multiple sclerosis: a case report. Diseases of the Nervous System 1977; 38: 210–211
   PubMedGoogle Scholar
• Kisser W., Harrer G. Amino acid determinations of serum of patients with multiple sclerosis. Wiener Klinishce Wochenschrift 1974; 86: 80–82
   PubMed Web of Science ®Google Scholar
• Kripke D. F., Risch S. C., Janowsky D. Bright white light alleviates depression. Psychiatry Research 1983; 10: 105–112
   PubMed Web of Science ®Google Scholar
• Kronfol Z. Multiple sclerosis and depression. Archives of Neurology 1985; 42: 310
   PubMedGoogle Scholar
• Lewy A. J., Wehr T. A., Gold P. W., Goodwin F. K. Plasma melatonin in manic-depressive illness. Catecholamines: basic and clinical frontiers, E. Usdin, I. J. Kopen, J. Barchas. Pergamon Press, Oxford 1979; Vol. 2: 1173–1175
   Google Scholar
• Lewy A. J., Wehr T. A., Goodwin F. K., Newsome D. A., Rosenthal N. E. Manic depressive patients may be supersensitive to light. Lancet 1981; 1: 383–384
   PubMed Web of Science ®Google Scholar
• Lewy A. J., Nurnberg J. I., Wehr T. A., Pack D., Becker L. E., Powell R. L., Newsome D. A. Supersensitivity to light: Possible trait marker for manic depressive illness. American Journal of Psychiatry 1985; 142: 725–727
   PubMed Web of Science ®Google Scholar
• Maestroni G. J. M., Conti A., Pierpaoli W. The pineal gland and the circadian, opiatergic, immunoregulatory role of melatonin. Annals of the New York Academy of Sciences 1987a; 496: 67–77
   PubMed Web of Science ®Google Scholar
• Maestroni G. J. M., Conti A., Pierpaoli W. Melatonin counteracts the effect of acute stress on the immune system via an opiatergic system. Fundamentals and clinics in pineal research, G. P. Trentini, C. DeGaetani, P. Pevet. Raven Press, New York 1987; vol. 44: 277–279
   Google Scholar
• Mapelli G., Ramelli E. Manic syndrome associated with multiple sclerosis: secondary mania?. Acta Psychiatrica Belgica 1981; 81: 337–349
   PubMedGoogle Scholar
• Miles A., Philbrick D. R. S. Melatonin and psychiatry. Biological Psychiatry 1988; 23: 405–425
   PubMed Web of Science ®Google Scholar
• Monaco F., Fumero S., Mondino A., Mutani R. Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases. Journal of Neurology, Neurosurgery and Psychiatry 1979; 42: 640–641
   PubMed Web of Science ®Google Scholar
• Persinger M. A., Ludwig H. W., Ossenkopp K. P. Psychophysiological effects of extremely low frequency electromagnetic fields: a review. Perceptual and Motor Skills 1973; 36: 1131–1159
   Web of Science ®Google Scholar
• Peselow E. D., Deutsch S. I., Fieve R. R. Coexistent manic symptoms and multiple sclerosis. Psychosomatics 1981; 22: 824–825
   PubMed Web of Science ®Google Scholar
• Prineas J. W., Wright R. G. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Laboratory Investigations 1978; 38: 409–421
   PubMed Web of Science ®Google Scholar
• Reiter R. J. The pineal gland. Raven Press, New York 1984
   Google Scholar
• Schiffer R. B., Wineman N. M., Weitkamp L. R. Association between bipolar affective disorder and multiple sclerosis. American Journal of Psychiatry 1986; 143: 94–95
   PubMed Web of Science ®Google Scholar
• Soloman J. G. Multiple sclerosis masquerading as lithium toxicity. Journal of Nervous and Mental Disease 1978; 166: 663–665
   PubMedGoogle Scholar
• Sonninen V., Riekkinen P., Rinne U. K. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology 1973; 23: 760–763
   PubMed Web of Science ®Google Scholar
• Surridge D. An investigation into some psychiatric aspects of multiple sclerosis. British Journal of Psychiatry 1969; 115: 749–764
   PubMed Web of Science ®Google Scholar
• Waksman B. H., Reynolds W. E. Multiple sclerosis as a disease of immune regulation. Proceedings of the Society of Experimental Biology and Medicine 1984; 175: 282–294
   PubMed Web of Science ®Google Scholar
• Weiner H. L., Hauser S. L. Neuroimmunology. I: Immunoregulation in neurological disease. Annals of Neurology 1982; 11: 437–449
   PubMed Web of Science ®Google Scholar
• Weiner H. L., Hafler D. A. Immunotherapy of multiple sclerosis. Annals of Neurology 1988; 23: 211–222
   PubMed Web of Science ®Google Scholar
• Weinschenker B. G., Ebers G. C. The natural history of multiple sclerosis. Canadian Journal of Neurological Sciences 1987; 14: 255–261
   PubMed Web of Science ®Google Scholar
• Whitlock F. A., Siskind M. M. Depression as a major symptom of multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1980; 43: 861–865
   PubMed Web of Science ®Google Scholar
• Wisniewski H. M., Keith A. B. Chronic relapsing experimental allergic encephalomyelitis: An experimental model of multiple sclerosis. Annals of Neurology 1977; 1: 144–148
   PubMed Web of Science ®Google Scholar
• Wuthrich R., Rieder H. P. The seasonal incidence of multiple sclerosis in Switzerland. European Neurology 1970; 3: 257–264
   PubMed Web of Science ®Google Scholar
• Yocca F. D., DePaul Lynch V., Friedman E. Effect of chronic lithium treatment on rat pineal rhythms: N-acetyltransferase, N-acetylserotinin and melatonin. Journal of Pharmacology and Experimental Therapeutics 1983; 226: 733–737
   PubMed Web of Science ®Google Scholar
• Young L. D., Taylor I., Holmstrom V. Lithium treatment of patients with affective illness associated with organic brain symptoms. American Journal of Psychiatry 1977; 134: 1405–1407
   PubMedGoogle Scholar